Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Credit agrmnt [a]
Quarterly results
Appointed director
CC transcript
GEN PROBE INC (GPRO) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/05/2016 CT ORDER Form CT ORDER - Confidential treatment order
02/22/2013 EFFECT Form EFFECT - Notice of Effectiveness
02/21/2013 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
08/13/2012 15-12G Form 15-12G - Securities registration termination [Section 12(g)]
08/13/2012 POS AM Form POS AM - Post-Effective amendments for registration statement
08/13/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
08/13/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
08/13/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
08/13/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
08/13/2012 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
08/01/2012 8-K Quarterly results
08/01/2012 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
07/31/2012 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
Docs: "Gen-Probe Receives Stockholder Approval For Proposed Merger With Hologic"
07/18/2012 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
07/11/2012 8-K Other Events, Financial Statements and Exhibits
Docs: "JOINT NEWS RELEASE",
"Retention and Severance Agreement, by and between Hologic, Inc. and Carl W. Hull",
"Change of Control Agreement, by and between Hologic, Inc. and Carl W. Hull"
07/10/2012 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
06/29/2012 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition
06/29/2012 PRER14A Form PRER14A - Preliminary Proxy Soliciting materials
06/20/2012 PRER14A Form PRER14A - Preliminary Proxy Soliciting materials
05/23/2012 8-K Form 8-K - Current report
05/18/2012 PREM14A Form PREM14A - Preliminary proxy statements relating to merger or acquisition
05/08/2012 10-Q Quarterly Report for the period ended March 31, 2012
05/08/2012 PRN FDA Clears Gen-Probe's PANTHER® System for use with APTIMA Combo 2® Assay
05/03/2012 PRN Gen-Probe Withdraws from Previously Announced Investor Presentations
05/01/2012 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
05/01/2012 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
05/01/2012 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
04/30/2012 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
04/30/2012 ARS Form ARS - Annual Report to Security Holders
04/30/2012 8-K Quarterly results
Docs: "Gen-Probe Reports Financial Results for the First Quarter of 2012 - Company Posts Non-GAAP EPS of $0.55 and GAAP EPS of $0.49 - - Total Revenues of $153.4 Million Achieved on Strength of Women's Health Franchise - - Gen-Probe to be Acquired by Hologic for $82.75 per Share in Cash -"
04/30/2012 8-K Other Events, Financial Statements and Exhibits
Docs: "HOLOGIC TO ACQUIRE GEN-PROBE"
04/30/2012 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
04/30/2012 PRN Gen-Probe Reports Financial Results for the First Quarter of 2012
04/30/2012 TRN Gen-Probe's CEO Discusses Q1 2012 Results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy